Lv41
410 积分 2025-01-12 加入
Camrelizumab plus carboplatin and pemetrexed versus chemotherapy alone in chemotherapy-naive patients with advanced non-squamous non-small-cell lung cancer (CameL): a randomised, open-label, multicentre, phase 3 trial
2小时前
待确认
Differential Immune-Related Microenvironment Determines Programmed Cell Death Protein-1/Programmed Death-Ligand 1 Blockade Efficacy in Patients With Advanced NSCLC
4小时前
已完结
Classifying Cancers Based on T-cell Infiltration and PD-L1
4小时前
已完结
Adaptive immune resistance at the tumour site: mechanisms and therapeutic opportunities
4小时前
已完结
Multiplexed imaging of tumor immune microenvironmental markers in locally advanced or metastatic non‐small‐cell lung cancer characterizes the features of response to PD‐1 blockade plus chemotherapy
11天前
已完结
Somatostatin Receptor-Directed Theranostics in Esthesioneuroblastoma
18天前
已完结
FAP-Targeted SPECT/CT and PET/CT Imaging for Breast Cancer Patients
21天前
已完结
Rosai-Dorfman Disease Mimicking Metastasis to the Spleen From Breast Cancer
21天前
已完结
Breast Metastases From ACTH Secreting Thymic Carcinoid
21天前
已完结
Spatial proximity of tumor-immune interactions predicts patient outcome in hepatocellular carcinoma
1个月前
已完结
皖公网安备34019202002308
